More...Snapshot
Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.).
The Asia-Pacific Mitomycin C market will reach xxx Millio
Table of Content
1 Industry Overview
1.1 Mitomycin C Industry
1.1.1 Overview
1.1.2 Development of Mitomycin C
1.2 Market Segment
1.2.1 By Product Type
1.2.2 By Application
1.3 Asia-Pacific Overview
2 Major Companies List
2.1 Kyowa-kirin (Company Profile, Products & Services, Sales Data etc.)
2.2 Intas Pharmaceuticals (Company Profile, Products &